Latest News in the pharma Industry

Market News

Biopharma stages a strong recovery over the first half even as M&A deals disappoint

Biopharma stages a strong recovery over the first half even as M&A deals disappoint

4 Aug 2017

EP Vantage releases half-year reviews of pharma & biotech and medtech performance.

Read more 
IDT launches first Cas9 enzyme that drastically reduces CRISPR off-target effects without significant loss of on-target activity

IDT launches first Cas9 enzyme that drastically reduces CRISPR off-target effects without significant loss of on-target activity

3 Aug 2017

The launch represents a major step towards therapeutic use of CRISPR.

Read more 
Baxter completes acquisition of Claris Injectables, expanding generic injectable medicines portfolio

Baxter completes acquisition of Claris Injectables, expanding generic injectable medicines portfolio

2 Aug 2017

Baxter plans to invest in further increasing Claris Injectables’ capacity and capabilities, including adding new aseptic manufacturing and lyophilization.

Read more 
TraceLink expands offering with ROC IT Solutions acquisition

TraceLink expands offering with ROC IT Solutions acquisition

2 Aug 2017

Company can now offer solutions for serialized receiving, picking, shipping, returns, deactivation, aggregation, de-aggregation, label printing and tag management of pharmaceutical products.

Read more 
Cherwell publishes Cleanroom Decontamination Guide

Cherwell publishes Cleanroom Decontamination Guide

31 Jul 2017

Guide aims to help the operator understand the complex protocols and heavily regulated procedures associated with pharmaceutical cleanrooms.

Read more 
STA Pharmaceutical merges with WuXi¹s Pharmaceutical Development Services Division

STA Pharmaceutical merges with WuXi¹s Pharmaceutical Development Services Division

31 Jul 2017

The merger enables STA to advance NCEs from pre-clinical stage to New Drug Application and to market faster and more efficiently for pharma and biotech customers.

Read more 
BMS and Clovis Oncology announce a broad clinical collaboration to evaluate combination of Opdivo and Rubraca

BMS and Clovis Oncology announce a broad clinical collaboration to evaluate combination of Opdivo and Rubraca

31 Jul 2017

Pivotal Phase III trials planned for 2017 will evaluate Rubraca + Opdivo, Rubraca as monotherapy, and Opdivo as monotherapy in first line maintenance treatment for advanced ovarian and advanced triple-negative breast cancers.

Read more 
Arch Biopartners' GMP manufacturing of AB569 on schedule

Arch Biopartners' GMP manufacturing of AB569 on schedule

30 Jul 2017

Dalton Pharma Services is preparing glass vials in three varying dose formulations for the clinical kits needed to support the Phase I safety trial for AB569 at the CVAMC later this year.

Read more 
AstraZeneca and Merck establish oncology collaboration

AstraZeneca and Merck establish oncology collaboration

30 Jul 2017

Collaboration aims to maximize the potential of PARP and MEK inhibitors in combination with PD-L1/PD-1 medicines, based on growing scientific evidence that these combinations offer new potential for the treatment of a range of tumor types.

Read more 
Torbay Pharmaceuticals opens new £26 million pharmaceutical manufacturing unit

Torbay Pharmaceuticals opens new £26 million pharmaceutical manufacturing unit

30 Jul 2017

The new facilities enable to company to further grow and flourish.

Read more 
Pall introduces proprietary bioreactor control system

Pall introduces proprietary bioreactor control system

27 Jul 2017

The mPath bioreactor control system is the first to be developed and delivered by a technology supplier specifically for their product line, allowing full access to bioreactor capabilities that current commercial solutions cannot provide.

Read more 
CPhI Annual Reports - how accurate were they 5 years on?

CPhI Annual Reports - how accurate were they 5 years on?

27 Jul 2017

The CPhI predictions foresaw advancement in QbD, continuous processing, and a dramatic rise in FDA warning letters.

Read more